These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 169754)

  • 61. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.
    Paridaens R; Sylvester RJ; Ferrazzi E; Legros N; Leclercq G; Heuson JC
    Cancer; 1980 Dec; 46(12 Suppl):2889-95. PubMed ID: 7448734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
    Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
    Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.
    Wortman JE; Rundles RW; Moore JO; McCarty KS; McCarty KS
    Med Pediatr Oncol; 1979; 7(3):277-83. PubMed ID: 542192
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Hormonal receptors of malignant breast tumors].
    Heuson JC; Longeval E; Leclercq G; Mattheiem WH
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4 SUPPL 2():207-14. PubMed ID: 172552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Selection of patients with breast cancer with regard to endocrine therapy].
    Cikes M; Pettavel J
    Schweiz Med Wochenschr; 1977 Nov; 107(46):1645-55. PubMed ID: 199940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormone receptors in male breast carcinoma.
    Ruff SJ; Bauer JE; Keenan EJ; Moseley HS; Fletcher WS
    J Surg Oncol; 1981; 18(1):55-9. PubMed ID: 6270468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
    Leake RE; Laing L; Calman KC; Macbeth FR; Crawford D; Smith DC
    Br J Cancer; 1981 Jan; 43(1):59-66. PubMed ID: 7459239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.
    Engelsman E; Persijn JP; Korsten CB; Cleton FJ
    Br Med J; 1973 Jun; 2(5869):750-2. PubMed ID: 4352316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of progesterone receptors in the management of advanced breast cancer.
    Bloom ND; Tobin EH; Schreibman B; Degenshein GA
    Cancer; 1980 Jun; 45(12):2992-7. PubMed ID: 7388743
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Editorial: Hormone receptors and breast cancer.
    Br Med J; 1976 Jul; 2(6027):67-8. PubMed ID: 179660
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical significance of estrogen receptors in human breast cancer.
    Olsnes S; Pihl A
    Biomedicine; 1974 Nov; 20(6):377-83. PubMed ID: 4376029
    [No Abstract]   [Full Text] [Related]  

  • 76. Infiltrating ductal / lobular carcinoma: an evaluation of prognostic factors in primary breast cancer.
    Salazar EL; Calzada L; Pedron N
    Arch AIDS Res; 1996; 10(1-2):73-82. PubMed ID: 12320022
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The immunoendocrinology of estrophilin.
    Jensen EV; Greene GL; Closs LE; DeSombre ER
    Adv Exp Med Biol; 1979; 117():1-16. PubMed ID: 474273
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improved biochemical characterization of breast cancer as a guide to hormonal treatment.
    Wagner RK; Jungblut PW
    Recent Results Cancer Res; 1980; 71():3-10. PubMed ID: 7367736
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The importance of treatment sequence in advanced and metastatic carcinoma of the breast.
    Awrich AE; Peetz ME; Moseley HS; Keenan E; Davenport CE; Fletcher WS
    J Surg Oncol; 1982 Sep; 21(1):9-17. PubMed ID: 7109642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.